December 15, 2021
DELTALAB is a European leader in the design, manufacture and distribution of consumables, reagents and laboratory equipment for the Healthcare Diagnostics, Life Sciences Research, Industrial and Food Safety sectors.
TALDE and ESPIGA have sold their stake in Deltalab to SCG Packaging Public Company Limited (“SCGP”) that takes place after the successful development of the Company, which has exceeded the objectives established in the business plan.
The closing of the transaction has taken place after receiving approval by the National Markets and Competition Commission (CNMC) and the Council of Ministers, as it was subject to foreign investment screening.
José Sáez, who has been a reference shareholder and top executive of Deltalab for the last fifteen years, and the current management team will continue to be part of the shareholding and lead the Company with the objective of continuing to drive its growth.
Founded in 1976 and headquartered in Rubí, DELTALAB is one of the leading European companies in the design, manufacture and distribution of consumables, reagents and laboratory equipment for the Healthcare Diagnostics, Life Sciences Research, Industrial and Food Safety sectors.
DELTALAB has consolidated its market position over the last 10 years by increasing its revenues from €20MM in 2010 to more than €70MM in 2020, expanding its international presence and developing new high value-added products.
SCGP is part of The Siam Cement Public Company Limited ("SCC"), one of Thailand's largest industrial conglomerates with FY2020 consolidated revenues of USD 12.8 billion and a market capitalization of USD 13.4billion.
SCGP is the largest integrated packaging and paper company in Southeast Asia, with 2020 consolidated revenues of USD 2.97 billion and a market capitalization of USD 8.0 billion. SCC holds 70% of SCGP's equity.
This acquisition is in line with global megatrends, such as preventive healthcare and an aging society, which require an increasing number of laboratory diagnostic tests. The healthcare and medical supplies industry is a fast-growing segment, with an estimated market size of $26 billion in Europe and $48 billion in Asia Pacific.
SCGP's core focus lies in providing solutions to consumers and strives to grow into customized precision segments. Deltalab establishes the essentials for future expansions in rapidly growing Asia Pacific healthcare market, projected at approximately 7-9% annually. In the longer term, this transaction allows SCGP the footprint to accelerate its higher growth and higher value-added prospects.
Deltalab's shareholders were advised by Greenhill & Co and Cuatrecasas, while SCG Packaging was advised by Alantra and Baker McKenzie.